Form 4: Cross Country Healthcare Director Receives Equity Grant

Dwayne Allen, a Director at Cross Country Healthcare, received 18,680 restricted shares of common stock, vesting on December 18, 2025.

Summary

• Dwayne Allen, a Director of Cross Country Healthcare, Inc. (CCRN), acquired 18,680 shares of common stock.
• The shares are Restricted Stock Awards (RSAs) granted at a price of $0.
• These RSAs will vest on December 18, 2025.
• The grant date for these RSAs was approved by the Compensation Committee of the Board of Directors for December 18, 2025, instead of the originally planned March 31, 2025.
• This change in grant date followed the termination of a Merger Agreement with Aya Holdings II Inc., Spark Merger Sub One Inc., and Aya Healthcare, Inc. on December 3, 2025.
• Following this transaction, Dwayne Allen beneficially owns 31,289 shares of common stock.

Sentiment

Score: 4

Explanation: While the insider equity grant itself is a neutral-to-positive event for aligning management interests, the underlying reason for the change in grant date – the termination of a merger agreement – is a significant negative event for the company's strategic direction and market perception. The overall sentiment is slightly negative due to the failed merger.

Positives

• A Director receiving equity compensation aligns their interests with those of shareholders, potentially motivating long-term performance.
• The grant of 18,680 restricted shares at a $0 price represents a significant equity award for the director.

Negatives

• The termination of the Merger Agreement with Aya Holdings II Inc., Spark Merger Sub One Inc., and Aya Healthcare, Inc. on December 3, 2025, indicates a failed strategic initiative, which is generally a negative event for the company.

Future Outlook

The filing does not provide specific forward-looking statements or guidance beyond the vesting date of the restricted shares.

Management Comments

• The Compensation Committee of the Company's Board of Directors approved the number of RSAs to be granted on December 18, 2025, instead of March 31, 2025, following the termination of the Merger Agreement with Aya Holdings II Inc., Spark Merger Sub One Inc. and Aya Healthcare, Inc. on December 3, 2025.

Industry Context

This filing primarily details an insider compensation event and the termination of a specific merger agreement, rather than broader industry trends. The healthcare staffing industry, in which Cross Country Healthcare operates, is subject to various market dynamics, but this filing does not offer direct insights into those trends.

Corporate Governance

Related Party Transactions

• Dwayne Allen, a Director of Cross Country Healthcare, Inc., received 18,680 restricted shares of common stock as compensation.

Stakeholder Impact

• Shareholders: The grant of equity to a director aims to align management interests with shareholder value. However, the termination of the merger agreement could raise concerns about strategic execution and future growth prospects.
• Employees: No direct impact on employees is mentioned in this filing.
• Customers/Suppliers/Creditors: No direct impact on these stakeholders is mentioned in this filing.

Next Steps

• The 18,680 restricted shares granted to Dwayne Allen are scheduled to vest on December 18, 2025.

Key Dates

Keywords

Cross Country Healthcare, CCRN, Dwayne Allen, Form 4, Insider Transaction, Restricted Stock Award, Equity Compensation, Merger Termination, Corporate Governance